|
Yes, RDY is a Revenue - $1.5 B/yr company that is set up exactly for this and the pipeline is even more full than in the prior year. This is what RDY is suited for. And the global shift to generics is helping RDY all the way.
http://www.reuters.com/article/marketsNe... Sentiment : Strong Buy Rating :
 (No ratings) |
 |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|